Ironwood Hits Endpoints In GERD, But Analysts Unimpressed With Treatment Effect
Executive Summary
The GI specialty firm hopes it has a future blockbuster with the bile acid sequestrant after hitting multiple endpoints in Phase IIb, but the treatment effect compared to PPI therapy alone was below what was previously anticipated.